14th European Cytogenomics Conference , Montpellier, Fransa, 1 - 04 Temmuz 2023, ss.50
Slowing down or pausing growth often indicates a
health problem in the child. The main criteria of short
stature are the third height percentile, growth rate
below the 25th percentile, height 8.5 cm shorter than
the expected one, and bone age older than that of
chronological age (>2 SD). Medical history, physical
examination, and laboratory tests are of great
importance in the investigation of short stature, and
these procedures significantly contribute to eluc-
idating etiologic causes.
Short stature is divided into two categories, clinically
pathological and non-pathological, divided into
subgroups related to genetic causes: chromosomal,
single gene, and multifactorial factors.
This study evaluated the genetic etiology of 189
clinically diagnosed short-stature patients with
unknown underlying causes using cytogenetic and
molecular tests to elucidate the genetic etiology.
Patients with normal karyotypes were included in the
analysis of 10 genes (GH1, GHR, GHRH, GHSR,
IGF1, IGF1R, IGFALS, IGFBP3, SHOX, and
STAT5B) which was carried out on the Ion Torrent
platform. Mutations thought to have clinical impor-
tance were confirmed by Sanger sequencing, and
family studies were used for further investigation.
In five cases, significant mutations (BMP4, GHR,
IGSF1, LHX4, and PROKR2) were identified, only
one of which was previously reported. Three muta-
tions were also detected in healthy family members.
This panel of short stature-associated genes was
designed for the first time in Turkey. Its results are
expected to elucidate genetic factors that play a role in
the etiology of this phenotype, reveal genotype-
phenotype correlations, and contribute to personalized
genetic counseling. But, since short stature has a broad
genetic background, we think a gene panel is
insufficient. Using whole-exome or whole-genome
sequencing, the proper approach would be to
investigate index individuals, their parents, and
healthy controls.